Abbott Laboratories (ABT) FCF Payout Ratio (2009 - 2026)

Abbott Laboratories (ABT) has 18 years of FCF Payout Ratio data on file, last reported at 1.2 in Q1 2026.

• For the quarter ending Q1 2026, FCF Payout Ratio rose 9.0% year-over-year to 1.2; the trailing twelve-month figure through Mar 2026 stood at 0.57 (down 3.23% YoY), and the FY2025 full-year result was 0.56, down 7.85% from the prior year.
• FCF Payout Ratio climbed to 1.2 in Q1 2026, from 0.39 in the prior quarter.
• In the past five years, FCF Payout Ratio ranged from a high of 1.53 in Q1 2024 to a low of 0.36 in Q3 2022.
• A 5-year average of 0.71 and a median of 0.48 in 2022 frame the typical range for FCF Payout Ratio.
• Across the five-year window, FCF Payout Ratio surged 213.66% in 2023 and tumbled 47.34% in 2024, its largest moves.
• Tracing ABT's FCF Payout Ratio over 5 years: stood at 0.48 in 2022, then retreated by 18.9% to 0.39 in 2023, then advanced by 14.66% to 0.45 in 2024, then slipped by 12.05% to 0.39 in 2025, then soared by 205.61% to 1.2 in 2026.
• Business Quant data shows ABT's FCF Payout Ratio at 1.2 in Q1 2026, 0.39 in Q4 2025, and 0.45 in Q3 2025.